Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America, E-Book, 1st Edition

著者 :

Edited by Jennifer R. Brown︎, MD, PhD

This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown︎, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia

ISBNコード :

9780323896931

出版日 :

01-07-2021

この商品を最初にレビューする

製品フォーマットの選択 VitalSource eBook

VitalSource Bookshelf gives you access to content when, where, and how you want. When you read an eBook on VitalSource Bookshelf, enjoy such features as:

Access online or offline, on mobile or desktop devices.
Bookmarks, highlights and notes sync across all your devices.
Smart study tools such as note sharing and subscription, review mode, and Microsoft OneNote integration.
Search and navigate content across your entire Bookshelf library.
Interactive notebook and read-aloud functionality.
Look up additional information online by highlighting a word or phrase.

￥13,903

数量

製品フォーマットの選択 VitalSource eBook

￥13,903

カートに入れる

商品説明

著者情報

Edited by Jennifer R. Brown︎, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute, USA

製品詳細

詳細情報
ISBN Number	9780323896931
Description Author List	Edited by Jennifer R. Brown︎, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute, USA
Copyright Year	2021
Edition Number	1
Format	E-Book
Imprint	Elsevier
Page Count	240
Publication Date	1 Jul 2021
Stock Status	IN STOCK

Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic LeukemiaThe Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical ImplicationsPrognostic and Predictive Implications of Cytogenetics and GenomicsGenomics of Resistance to Targeted TherapiesFirst-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondBruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond IbrutinibShould Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase InhibitorsThe Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaCan Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond

レビュー

あなたのレビューを投稿する

登録ユーザーのみがレビューを書くことができます。ログインするか、アカウントを作成してください

https://shop.elsevier.jp/chronic-lymphocytic-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-e-book-9780323896931.html 301221 Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America, E-Book https://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323896931.jpg 13903 13903 JPY InStock /Medicine & Surgery/Hematology /eBooks /Medicine/Hematology /eBooks /eBooks /Medicine/Hematology /Medicine/Hematology /Product Format/E-Book /Product Format/E-Book /Product Format/E-Book /Product Format/E-Book 4431214 4388724 5054622 5054665 5255040 5259911 5803578 5936800 5936822 5936827 5936832 1 4182692 4335088 4886536 5054553 5145120 5259833 5799892 5803526 5936799 5936809 5936823 5936828 This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown︎, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown︎, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia 0 0 add-to-cart 9780323896931 2021 専門医 Edited by Jennifer R. Brown︎, MD, PhD 2021 1 E-Book Elsevier 240 2021/07/01 IN STOCK Edited by Jennifer R. Brown︎, MD, PhD, Professor of Medicine, Harvard Medical School,Director of CLL Center, Dana-Farber Cancer Institute, USA E-Book E-Book The Clinics: Internal Medicine 米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください